Public company info - Baytacare Pharmaceutical Co. Ltd. - H Shares , 08197.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Baytacare Pharmaceutical Co. Ltd. - H Shares, 08197.HK - Cash Flow 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12 2011-12 2010-12 2009-12 2008-12 2007-12 2006-12 2005-12
Net Cash Flow from Operating Activities 5,492 -19,491 -44,088 6,573 -6,414 9,669 25,286 20,744 -71,521 8,086 2,241 5,287 1,641 -3,674
Net Cash Flow from Return on Investments & Servicing of Finance 2 -606 15 -1,099 -1,369 -1,583 -1,776 -2,938 -938 28 14 -1,225 -1,580 -1,560
　Interest Received 2 20 15 0 5 2 18 23 30 28 14 2 0 9
　Interest Paid 0 -626 0 -1,099 -1,374 -1,585 -1,794 -2,961 -968 0 0 -1,227 -1,580 -1,569
　Dividend Received 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Dividend Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Others 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Cash Flow from Investing Activities 0 -40,686 2,561 4 14,904 -3,955 -15,600 -13,967 -2,568 -173 -1,146 23,761 -90 16,454
　Additions to Fixed Assets 0 -423 -1,533 0 -30 -555 0 -17 -2,568 -173 -1,276 -239 -90 -1,740
　Disposal of Fixed Assets 0 0 0 4 0 0 0 50 0 0 130 24,000 0 17,679
　Increase in Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Decrease in Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Net Cash Flow with Related Parties 0 0 8,000 0 -1,450 1,450 0 17,500 0 0 0 0 0 0
　Others 0 -40,263 -3,906 0 16,384 -4,850 -15,600 -31,500 0 0 0 0 0 515
Net Cash Flow before Financing Activities 5,494 -60,783 -41,512 5,478 7,121 4,131 7,910 3,839 -75,027 7,941 1,109 27,823 -29 11,220
Net Cash Flow from Financing Activities 0 0 102,731 -5,000 -10,550 -5,050 -9,420 -11,500 69,000 0 -10,000 -24,000 -500 0
　New Loans 0 0 0 0 0 0 0 0 69,000 0 0 0 24,000 24,500
　Loans Repayment 0 0 0 -5,000 -9,100 -6,500 -9,420 -29,000 0 0 -10,000 -24,000 -24,500 -24,500
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Equity Financing 0 0 94,731 0 0 0 0 0 0 0 0 0 0 0
　Net Cash Flow with Related Parties 0 0 8,000 0 -1,450 1,450 0 17,500 0 0 0 0 0 0
　Others 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Increase(Decrease) in Cash & Cash Equivalents 5,494 -60,783 61,219 478 -3,429 -919 -1,510 -7,661 -6,027 7,941 -8,891 3,823 -529 11,220
Cash & Cash Equivalents at Beginning of Year 919 61,702 483 5 3,434 4,353 5,863 13,524 19,551 11,610 20,501 16,678 17,207 5,987
Net Cash Flow due to Change in Exchange Rate/Others 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cash & Cash Equivalents at End of Year 6,413 919 61,702 483 5 3,434 4,353 5,863 13,524 19,551 11,610 20,501 16,678 17,207
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit Thousand Thousand Thousand Thousand Thousand Thousand Thousand
Auditor's Opinion 2 1 1 1 1 1 1 1 1 1 1 1 1 1

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

 
88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2024
Suntek Computer Systems Limited.
All rights reserved